Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

References for PMC Articles for PubMed (Select 20937112)

1.

International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS).

McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ.

Value Health. 2010 Dec;13(8):946-51. doi: 10.1111/j.1524-4733.2010.00767.x.

PMID:
20667058
2.
3.

International development of the Unidimensional Fatigue Impact Scale (U-FIS).

Doward LC, Meads DM, Fisk J, Twiss J, Hagell P, Oprandi NC, Grand'Maison F, Bhan V, Arbizu T, Kohlmann T, Brassat D, Eckert BJ, McKenna SP.

Value Health. 2010 Jun-Jul;13(4):463-8. doi: 10.1111/j.1524-4733.2010.00706.x. Epub 2010 Mar 11.

PMID:
20230543
4.

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.

Stargardt T, Gonder-Frederick L, Krobot KJ, Alexander CM.

Health Qual Life Outcomes. 2009 Oct 22;7:91. doi: 10.1186/1477-7525-7-91.

5.

The minimal detectable change cannot reliably replace the minimal important difference.

Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH.

J Clin Epidemiol. 2010 Jan;63(1):28-36. doi: 10.1016/j.jclinepi.2009.01.024. Epub 2009 Oct 1.

PMID:
19800198
6.

The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.

Colangelo KJ, Pope JE, Peschken C.

J Rheumatol. 2009 Oct;36(10):2231-7. doi: 10.3899/jrheum.090193. Epub 2009 Sep 1.

PMID:
19723907
7.

The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).

Doward LC, McKenna SP, Meads DM, Twiss J, Eckert BJ.

Mult Scler. 2009 Sep;15(9):1092-102. doi: 10.1177/1352458509106513. Epub 2009 Jun 25.

PMID:
19556315
8.

The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS).

Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B.

Mult Scler. 2009 Oct;15(10):1228-38. doi: 10.1177/1352458509106714. Epub 2009 Jun 25.

PMID:
19556314
9.

Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis.

Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A, Hoffmann F, Käfferlein W, Kausch U, Liedtke M, Kirchmeier J, Gmünd S, Richter A, Schicklmaier P, Niemczyk G, Wernsdörfer C, Hartung HP; "Mensch im Mittelpunkt" Study Group.

Eur J Neurol. 2009 Jun;16(6):713-20.

PMID:
19475754
10.

Multiple sclerosis beyond EDSS: depression and fatigue.

Ziemssen T.

J Neurol Sci. 2009 Feb 1;277 Suppl 1:S37-41. doi: 10.1016/S0022-510X(09)70011-5. Review.

PMID:
19200865
11.

Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference.

Turner D, Schünemann HJ, Griffith LE, Beaton DE, Griffiths AM, Critch JN, Guyatt GH.

J Clin Epidemiol. 2009 Apr;62(4):374-9. doi: 10.1016/j.jclinepi.2008.07.009. Epub 2008 Nov 14.

PMID:
19013766
12.

The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease.

Puhan MA, Frey M, Büchi S, Schünemann HJ.

Health Qual Life Outcomes. 2008 Jul 2;6:46. doi: 10.1186/1477-7525-6-46.

13.

Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.

Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM.

Neurology. 2008 Mar 25;70(13 Pt 2):1084-91. doi: 10.1212/01.wnl.0000288179.86056.e1. Epub 2008 Jan 9.

PMID:
18184917
14.

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer.

Pickard AS, Neary MP, Cella D.

Health Qual Life Outcomes. 2007 Dec 21;5:70. Erratum in: Health Qual Life Outcomes. 2010;8:4.

15.

A prospective study of patterns of fatigue in multiple sclerosis.

Lerdal A, Celius EG, Krupp L, Dahl AA.

Eur J Neurol. 2007 Dec;14(12):1338-43. Epub 2007 Sep 26.

PMID:
17903208
16.

Is a 20% change in MSFC components clinically meaningful?

Contelloe L, Hutchinson M.

Mult Scler. 2007 Sep;13(8):1076. No abstract available.

PMID:
17895297
17.

Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.

Montel SR, Bungener C.

Mult Scler. 2007 Apr;13(3):393-401. Epub 2007 Jan 29.

PMID:
17439909
18.

The natural history of relapses in multiple sclerosis.

Vollmer T.

J Neurol Sci. 2007 May 15;256 Suppl 1:S5-13. Epub 2007 Mar 7. Review.

PMID:
17346747
19.

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health.

Health Qual Life Outcomes. 2006 Oct 11;4:79.

20.

Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Walters SJ, Brazier JE.

Qual Life Res. 2005 Aug;14(6):1523-32. Review.

PMID:
16110932
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk